CT
GCVRZ

Clearstead Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Clearstead Trust’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 195
2019
Q4 		$0 Hold
100
– – ﹤0.01% 208
2019
Q3 		$0 Hold
100
– – ﹤0.01% 206
2019
Q2 		$0 Hold
100
– – ﹤0.01% 209
2019
Q1 		$1K Hold
100
– – ﹤0.01% 194
2018
Q4 		$0 Hold
100
– – ﹤0.01% 245
2018
Q3 		$0 Hold
100
– – ﹤0.01% 220
2018
Q2 		$0 Buy
+100
New +$47 ﹤0.01% 215
2018
Q1 		– Sell
-100
Closed – – 214
2017
Q4 		$0 Hold
100
– – ﹤0.01% 233
2017
Q3 		$0 Hold
100
– – ﹤0.01% 242
2017
Q2 		$0 Buy
+100
New +$41 ﹤0.01% 242

Clearstead Trust's GCVRZ Position: Q1 2020 in Review

Clearstead Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 100 shares.

Clearstead Trust first reported a position in GCVRZ in Q2 2017 and held it in 10 quarters. The position peaked at $1K in Q1 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Clearstead Trust reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Clearstead Trust sold 100 Sanofi Contingent Value Rights shares in Q1 2020.
  • Clearstead Trust first reported a position in Sanofi Contingent Value Rights in Q2 2017 and held it in 10 quarters.
  • Clearstead Trust's Sanofi Contingent Value Rights position peaked at $1K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Clearstead Trust's 13F filing for Q1 2020, filed 12 May 2020.